India

Tuberculosis profile

| High TB burden | High HIV burden | High MDR-TB burden |

Population 2013

1 252 million

Estimates of TB burden * 2013

Mortality (excludes HIV+TB)
Mortality (HIV+TB only)
Prevalence (includes HIV+TB)
Incidence (includes HIV+TB)
Incidence (HIV+TB only)
Case detection, all forms (%)
Estimates of MDR-TB burden * 2013
% of TB cases with MDR-TB
MDR-TB cases among notified pulmonary
TB cases

Number (thousands)
240 (150350)
38 (3144)
2 600 (1 8003 700)
2 100 (2 0002 300)
120 (100140)
58 (5461)
New
2.2 (1.92.6)

Rate
(per 100 000 population)
19 (1228)
3 (2.53.5)
211 (143294)
171 (162184)
9.7 (8.311)

New **
621 762
292 926
226 557

Relapse
102 660

1 243 905
171 712
1 415 617

1994

1998

2002

2006

2010

2006

2010

400
200
0
1990

1994

1998

2002

(Rate per 100 000 population per year)

200
100

New

TB/HIV 2013
TB patients with known HIV status
HIV-positive TB patients
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)
HIV-positive TB patients on antiretroviral therapy (ART)
HIV-positive people screened for TB
HIV-positive people provided with IPT
Treatment success rate
New and relapse cases registered in 2012
Previously treated cases, excluding relapse, registered in 2012
HIV-positive TB cases, all types, registered in 2012
RR-/MDR-TB cases started on second-line treatment in 2011
XDR-TB cases started on second-line treatment in 2011

0
1990

Prevalence

Among 1 243 905 new and relapse cases:

64 726 (5%) cases aged under 15 years;
Reported cases of RR-/MDR-TB 2013
Cases tested for RR-/MDR-TB
Laboratory-confirmed RR-/MDR-TB cases
Patients started on MDR-TB treatment

20

(Rate per 100 000 population)

600

20 000 (17 00024 000) 41 000 (30 00052 000)

Total new and relapse

Previously treated, excluding relapses
Total cases notified

40

Mortality (excludes HIV+TB)

Retreatment
15 (1119)

TB case notifications 2013

Pulmonary, bacteriologically confirmed
Pulmonary, clinically diagnosed
Extrapulmonary

***
(Rate per 100 000 population per year)
60

Retreatment

Number
887 903
44 027
41 827
38 754
1 063 644

Total **
248 341
35 385
20 763
(%)
(63)
(5)
(95)
(88)

0
1990

1994

2002

2006

Notified (new and relapse)

Incidence (HIV+TB only)

2010

Incidence

(Number of patients)
40000
20000
0
2003

(%)
88
74
77
50

1998

2005

2007

2009

2011

HIV-positive TB patients
on CPT
on ART
Treatment success rate (%)
80
40

Laboratories 2013
Smear (per 100 000 population)
Culture (per 5 million population)
Drug susceptibility testing (per 5 million population)
Sites performing Xpert MTB/RIF
Is second-line drug susceptibility testing available?
Financing TB control 2014
National TB programme budget (US$ millions)
% Funded domestically
% Funded internationally
% Unfunded
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history

1.0
0.2
0.2
54
Yes, in country

252
66%
34%
0%

0
1995 1997 1999 2001 2003 2005 2007 2009 2011
New
Retreatment
New and relapse
Retreatment, excluding
relapse
HIV-positive
RR-/MDR-TB
XDR-TB
Total budget (US$ millions)
300
200
100
0
2010

__
__

2011

Funded domestically
Unfunded

Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
Generated: 2015-01-11

2012

__

2013

2014

Funded internationally

Data: www.who.int/tb/data